
FDA Approves Avastin Biosimilar Agent, Jobevne
The US Food and Drug Administration (FDA) has approved bevacizumab-nwgd (Jobevne, Biocon Biologics Ltd), a biosimilar to bevacizumab (Avastin, Genentech), for intravenous use across multiple cancer types. Approval was based on “a comprehensive package of …